CRO Intel

Dashboard Companies Opportunity Signals Clinical Trials Hiring Intelligence Funding Publications FDA Settings

Company Intelligence

Discover companies with clinical, regulatory and hiring signals
Total Companies

6,643

Company Clinical Trials FDA Signals Hiring Opportunity Confidence Last Seen
Pliant Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Plurogen Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Plus Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Plx Pharma — — —
60
36% 		7/17/2026 View Intelligence
Pmv Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Pneuma Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Pnp Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Point Biopharma A Wholly Owned Subsidiary Of Eli Lilly And — — —
60
36% 		7/17/2026 View Intelligence
Point Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Polaris Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Polaryx Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Polpharma Biologics — — —
60
36% 		7/17/2026 View Intelligence
Polpharma Biologics International — — —
60
36% 		7/17/2026 View Intelligence
Polpharma Foundation For Development Of Polish Pharmacy And Medicine — — —
60
36% 		7/17/2026 View Intelligence
Polpharma Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Poly Pharmaceuticals — — —
60
42% 		7/20/2026 View Intelligence
Polyneuron Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Polyphenon Pharma — — —
60
36% 		7/17/2026 View Intelligence
Polysan Scientific & Technological Pharmaceutical 2 trials — —
60
36% 		7/17/2026 View Intelligence
Poniard Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Poolbeg Pharma — — —
60
36% 		7/17/2026 View Intelligence
Popular Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Portal Therapeutics 1 trials — —
60
36% 		7/17/2026 View Intelligence
Portola Pharmaceuticals 1 trials — —
60
36% 		7/17/2026 View Intelligence
Portola Pharmaceuticals (a Wholly Owned Subsidiary Of Alexion Pharmaceuticals) — — —
60
36% 		7/17/2026 View Intelligence
Porton Biopharma — — —
60
36% 		7/17/2026 View Intelligence
Poseida Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Poseida Therapeutics A Member Of The Roche Group — — —
60
36% 		7/17/2026 View Intelligence
Potentia Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Powder (guangzhou) Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Powder Pharmaceuticals (hk) — — —
60
36% 		7/17/2026 View Intelligence
Ppc Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Praecis Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Prana Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Prasco Laboratories — — —
60
41% 		7/20/2026 View Intelligence
Prd Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Precedo Pharmaceuticals 2 trials — —
60
36% 		7/17/2026 View Intelligence
Precigen — — —
60
40% 		7/20/2026 View Intelligence
Precisio Biotix Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Precision Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Precision Dose — — —
60
42% 		7/20/2026 View Intelligence
Precision Nuclear — — —
60
39% 		7/20/2026 View Intelligence
Precision Therapeutics 4 trials — —
60
36% 		7/17/2026 View Intelligence
Predictive Biosciences 2 trials — —
60
36% 		7/17/2026 View Intelligence
Preferred Pharmaceuticals — — —
75
42% 		7/20/2026 View Intelligence
Prelude Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Premier Brands of America — — —
60
42% 		7/20/2026 View Intelligence
Premier Dental Products — — —
60
41% 		7/20/2026 View Intelligence
Premier Value Alliance — — —
60
40% 		7/20/2026 View Intelligence
Premiere Enterprises — — —
60
40% 		7/20/2026 View Intelligence
Showing 4701 - 4750 of 6,643 companies